Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.

S Kim1, S M Liva, M A Dalal

  • 1Department of Neurology, University of California Los Angeles School of Medicine, USA.

Neurology
|April 24, 1999
PubMed
Summary

Estriol treatment significantly reduced experimental autoimmune encephalomyelitis (EAE) severity in mice. This suggests estriol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic analysis of field germination in soybean (Glycine max. (L) merill.).

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.

Neuroscience·2008
Same author

Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2006
Same author

Hormone-based therapies in MS.

International MS journal·2003
Same author

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects.

Molecular psychiatry·2003
Same author

Onset of multiple sclerosis associated with anti-TNF therapy.

Neurology·2001

Area of Science:

  • Neuroimmunology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Experimental autoimmune encephalomyelitis (EAE) is a T helper 1 (Th1)-mediated autoimmune demyelinating disease, serving as a model for multiple sclerosis (MS).
  • Both EAE and MS exhibit amelioration during late pregnancy, hinting at hormonal influences on immune responses.

Purpose of the Study:

  • To investigate the therapeutic potential of estriol in treating experimental autoimmune encephalomyelitis (EAE).
  • To explore estriol's efficacy in other cell-mediated autoimmune diseases.
  • To understand the immunological mechanisms underlying estriol's effects in EAE.

Main Methods:

  • Estriol, progesterone, or placebo pellets were administered to mice during the effector phase of adoptive EAE.
  • Disease severity was assessed using clinical scores.

Related Experiment Videos

  • Autoantigen-specific humoral and cellular immune responses were analyzed.

    • Main Results:

    • Estriol treatment significantly reduced EAE severity compared to placebo; progesterone had no effect.
    • Estriol administration led to increased levels of anti-myelin basic protein (MBP) IgG1 antibodies.
    • MBP-specific T-lymphocyte responses in estriol-treated mice showed elevated interleukin-10 (IL-10) production, primarily from T lymphocytes.

    Conclusions:

    • Estriol, a hormone associated with pregnancy-related immune modulation, demonstrates therapeutic potential for EAE.
    • These findings suggest estriol could be a novel treatment for multiple sclerosis and other Th1-mediated autoimmune diseases.
    • The study highlights the role of IL-10 in estriol-mediated immune suppression in EAE.